Over 40 medications, including ascorbic acid at high doses and sulfonamides, have been hypothesized to be linked to hemolysis in G6PD-deficient individuals, but the evidence supporting most of these medications is lacking.Clinical Pharmacogenetics Implementation Consortium
the NNMT inhibitor literature does not, with every published in-vivo study of 5-Amino-1MQ conducted in rodents and no NNMT inhibitor approved in any jurisdiction
Atherosclerosis progression, as a chronic inflammatory mechanism, is characterized by immune system dysregulation associated with increased pro-inflammatory cytokine production, including interleukin 6 (IL-6), tumor necrosis factor- (TNF-), and IL-1, as well as pattern recognition receptor proteins like CRP (170, 261267)
However, strong human research has not established that combining the two produces better results than using either peptide alone
Partner pharmacies described by altRx as USA-certified: According to altRx, the brand partners with multiple pharmacies that fulfill any compounded medication that is prescribed